Bharat Biotech's Covaxin is overall 77.8 per cent effective "against symptomatic COVID-19", the vaccine maker said today in a statement, citing the data from the third phase of clinical trials. The data, however, is yet to be peer-reviewed.
from Videos https://ift.tt/3hosUHG
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment